Clinical trial
A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain…
NCT00092300 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00092300 |
|---|---|
| Title | A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED) |
| Official title | A Randomized, Double-Blind, Placebo- and Active-Comparator-Controlled, Single Dose Study of the Effect of Rofecoxib 50 mg and Valdecoxib 20 mg in Patients With Postoperative Dental Pain |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Postoperative Pain |
| Intervention type | Drug |
| Interventions | MK0966, rofecoxib, Comparator: valdecoxib |
| Enrollment | 450 |
| Start date | May 1, 2002 |
| Primary completion | Sep 1, 2002 |
| First posted | Sep 28, 2004 |
| Last update posted | Aug 4, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: